ClinicalTrials.gg
CompletedNCT04917575Updated Nov 16, 2026Results posted

Efficacy Trial of Life Simulation Game to Routinize Adolescent HIV Testing

An interventional study of Mobile Game and Mobile Application in Hiv, sponsored by George Washington University. Completed at 1 site in United States. Open to participants aged 13 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Primary conditionAcquired Immunodeficiency Syndrome(the registry's first term)UnverifiedIs this wrong?The registry often attaches Acquired Immunodeficiency Syndrome to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by George Washington University · Not applicable, Interventional, and Screening

How we know

Updated Nov 16, 2026Results postedStudy documents posted+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
309
Allocation
Randomized
Ages
13 Years to 24 Years
Sex
All
01

Study summary

This study will aim to assess the acceptability, usability and efficacy of using state-of-the-art video game technology to increase HIV testing among adolescents and young adults (AYA) ages 13-24. AYA often lack awareness of their personal risk of contracting HIV and where to go for testing and care. This lack of awareness has contributed to poor uptake of HIV testing among AYA despite engagement in high risk behaviors. The goal of this project is to harness this strong motivation to play games to increase HIV testing. Previous games for behavior change have yielded early success for increasing target behaviors among their sample populations, yet research on increasing HIV testing among AYA through gaming has been limited. This intervention builds on prior formative work and is designed to offer AYA personally-tailored risk messages and supports their accessibility to HIV testing and prevention services through an innovative gaming approach that is sharable over social media with in-game rewards for sharing the game with peers. The specific aim of this study is to determine the efficacy of a life-simulation game in changing HIV testing, knowledge, and risk behaviors among AYA at risk for HIV.

02

Conditions studied

  • Hiv

Browse trials for

Keywords

  • HIV prevention
  • HIV testing
  • mHealth
  • Pre-exposure prophylaxis (PrEP)
  • adolescents
  • interactive technology
03

In context

Acquired Immunodeficiency Syndrome Unverified

3,039 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 308 are open to participants now.

This study's enrollment of 309 is above the median of 96 across 2,254 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

George Washington University is the lead sponsor of 193 studies on the registry; 34 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 11 (79%) have results posted.

Compared within Acquired Immunodeficiency Syndrome, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
13 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • age 13-24
  • self-reported negative or unknown status
  • self-reported ever sexually active
  • resident of the DC metropolitan region which includes the District of Columbia, Maryland and Virginia for at least the next 6 months
  • Is able to provide or assent
  • able to complete all study procedures in English
  • has own mobile phones and be willing to use them for the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
309 participants (actual)

Study arms

  • Experimental
    Mobile Game

    Participants will engage with an enhanced life-simulation prototype of a playable interactive game to increase HIV testing, risk assessment tool, and HIV and pre-exposure prophylaxis (PrEP) locators embedded within the game.

    Other: Mobile Game

  • Active comparator
    Mobile Application

    Participants will engage with a mobile application that will include basic information on HIV basics (e.g., routes of transmission, data on the epidemiology of HIV among youth), prevention information on HIV testing and PrEP, as well as a link to the HIV risk estimator, and HIV testing and PrEP locators.

    Other: Mobile Application

Interventions

  • OtherMobile Game

    An enhanced life-simulation prototype of a playable interactive game to increase HIV testing.

  • OtherMobile Application

    A mobile application that will include basic information on HIV basics (e.g., routes of transmission, data on the epidemiology of HIV among youth), prevention information, and information on HIV testing and PrEP, as well as a link to the HIV risk estimator, and HIV testing and PrEP locators.

06

What researchers measure

Primary outcomes

  1. HIV Testing

    Self-reported HIV testing in the past 6 months

    Time frame: assessed at 6 months from enrollment

Secondary outcomes

  1. Number of Participants Intending to Test for HIV

    We counted the number of participants who intended to test for HIV after 6 months of follow up

    Time frame: assessed at 6 months after enrollment

  2. Mean HIV Knowledge Test Scores for the Two Groups

    Mean score on an 18-item HIV Knowledge test for each of the two groups with a score of 0 indicating no knowledge and 18 indicating maximum knowledge.

    Time frame: assessed at 6 months post enrollment

  3. PrEP Use/Uptake

    whether participant has been prescribed/taken PrEP

    Time frame: assessed at 6 months post enrollment

  4. HIV Testing Locator

    Number of times participant clicked on HIV testing locator link

    Time frame: assessed at 3 months post enrollment

  5. Mean PrEP Knowledge Score for Each of the Two Groups

    Mean score on a 13 item PrEP knowledge scale was calculated with possible scores ranging from 0 (no knowledge) to 13 (maximum knowledge)

    Time frame: assessed at 6 months post enrollment

07

Results

Posted Nov 16, 2026
Limitations and caveats
1\) we were only able to include English speaking participants who lived in the DC metropolitan region; 2) we did not recruit a large enough sample under 18 years of age to conduct further stratification by age, thereby limiting the representativeness and generalizability of our findings; 3) Study recruitment at clinical sites was limited due to the COVID-19 pandemic and subsequent operational changes at the clinic-level.

Participant flow

Participants were recruited online through social media advertisements, using community fliers, and through peer referral. Recruitment took place between November 2023 and May 2024. Potential participants were able to scan a QR code or click on an advertisement to complete an online screener that assessed their age, gender, sexual behaviors and orientation, state of residence, and availability of a reliable cell phone. Peer referral allowed eligible participants to recruit up to 3 peers

Participant flow — Overall Study
MilestoneMobile GameMobile Application
Started156153
Completed150149
Not completed64
Withdrew: Withdrawal by subject20
Withdrew: Did not complete follow up surveys44

Outcome measures

PrimaryHIV Testing

Self-reported HIV testing in the past 6 months

Time frame:
assessed at 6 months from enrollment
Reported as:
Count of participants · Participants
HIV Testing
ParticipantsMobile GameMobile Application
HIV Testing3248
SecondaryNumber of Participants Intending to Test for HIV

We counted the number of participants who intended to test for HIV after 6 months of follow up

Time frame:
assessed at 6 months after enrollment
Reported as:
Number · number of participants
Number of Participants Intending to Test for HIV
number of participantsMobile GameMobile Application
Number of Participants Intending to Test for HIV7485
SecondaryMean HIV Knowledge Test Scores for the Two Groups

Mean score on an 18-item HIV Knowledge test for each of the two groups with a score of 0 indicating no knowledge and 18 indicating maximum knowledge.

Time frame:
assessed at 6 months post enrollment
Reported as:
Mean · mean score on a scale
Mean HIV Knowledge Test Scores for the Two Groups
mean score on a scaleMobile GameMobile Application
Mean HIV Knowledge Test Scores for the Two Groups12.1 ± 2.511.4 ± 3.0
Statistical analysis
  • Mobile Game vs Mobile Application · likelihood ratio testing of mean differe · p = <0.01 (likelihood ratio testing p value was reported) · Mean difference (final values): 0.81 · 95% CI 0.14 to 1.48
SecondaryPrEP Use/Uptake

whether participant has been prescribed/taken PrEP

Time frame:
assessed at 6 months post enrollment
Reported as:
Count of participants · Participants
PrEP Use/Uptake
ParticipantsMobile GameMobile Application
PrEP Use/Uptake1114
SecondaryHIV Testing Locator

Number of times participant clicked on HIV testing locator link

Time frame:
assessed at 3 months post enrollment
Reported as:
Median · number of clicks
HIV Testing Locator
number of clicksMobile GameMobile Application
HIV Testing Locator2 (0 to 3)0 (0 to 1)
SecondaryMean PrEP Knowledge Score for Each of the Two Groups

Mean score on a 13 item PrEP knowledge scale was calculated with possible scores ranging from 0 (no knowledge) to 13 (maximum knowledge)

Time frame:
assessed at 6 months post enrollment
Reported as:
Mean · mean score on a scale
Mean PrEP Knowledge Score for Each of the Two Groups
mean score on a scaleMobile GameMobile Application
Mean PrEP Knowledge Score for Each of the Two Groups8.3 ± 3.28.0 ± 3.4

Adverse events

Collected over from enrollment until end of follow up at 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mobile Game0/150 (0%)0/150 (0%)0/150 (0%)
Mobile Application0/149 (0%)0/149 (0%)0/149 (0%)

Baseline characteristics

this is the overall number of participants that were eligible, randomized, and downloaded the control or intervention app

Age, Continuous
Age, Continuous(years)Mobile GameMobile ApplicationTotal
Mean20.7 ± 1.8420.8 ± 1.8420.7 ± 1.84
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Mobile GameMobile ApplicationTotal
male5467121
female7471145
other gender221133
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Mobile GameMobile ApplicationTotal
Hispanic any race322456
Non hispanic Asian322759
non hispanic black243458
non hispanic multiracial10616
non Hispanic white5152103
other race134
Region of Enrollment
Region of Enrollment(Participants)Mobile GameMobile ApplicationTotal
United States150149299
08

Study locations

1 site
  • George Washington University Milken School of Public Health
    Washington D.C., District of Columbia 20052, United States
09

References and documents

Publications

  • Castel AD, Wilbourn B, Trexler C, D'Angelo LD, Greenberg D. A Digital Gaming Intervention to Improve HIV Testing for Adolescents and Young Adults: Protocol for Development and a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2021 Jun 24;10(6):e29792. doi: 10.2196/29792. PubMed 34185022 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in May 2024, 6 months.

Results were first posted in Nov 2026, 2 years 6 months after primary completion.

Of 642 non-industry interventional studies with no phase under Acquired Immunodeficiency Syndrome, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 45. This study's 6 months is below that.

Counting every sponsor, half of 648 studies reached it within 29 months; a quarter within 17 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: start Jun 2021 → Nov 2023, primary completion Oct 2024 → May 2024 and completion Oct 2024 → May 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2021
First posted
Jun 8, 2021
StartActual
Nov 1, 2023was Jun 2021
Primary completionActual
May 1, 2024was Oct 2024
CompletionActual
May 1, 2024was Oct 2024
Results first posted
Nov 16, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 16, 2026
Start date
Jun 24, 2021→Nov 1, 2023
Nov 16, 2026
Primary completion
Oct 31, 2024→May 1, 2024
Nov 16, 2026
Study completion
Oct 31, 2024→May 1, 2024
Nov 16, 2026
Enrollment
300→309
Nov 16, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedHIV testingTestingTime frame: prior 6 months → assessed at 6 months from enrollment
Nov 16, 2026
Documents
Secondary outcomes
3 edited, 2 added, 9 removed
What changed in the outcomes
  • EditedIntentNumber of Participants Intending to testTest for HIVTime frame: baseline, 1, 3, 6 months → assessed at 6 months after enrollment
  • EditedPrEP useUse/uptakeUptakeTime frame: baseline, 1, 3, 6 months → assessed at 6 months post enrollment
  • EditedHIV locator useTesting LocatorTime frame: baseline, 1, 3, 6 months → assessed at 3 months post enrollment
  • AddedMean HIV Knowledge Test Scores for the Two GroupsTime frame: assessed at 6 months post enrollment
  • AddedMean PrEP Knowledge Score for Each of the Two GroupsTime frame: assessed at 6 months post enrollment
  • RemovedHIV knowledgeTime frame: baseline, 1, 3, 6 months
  • RemovedHIV risk perception and behaviorsTime frame: baseline, 1, 3, 6 months
  • RemovedKnowledge of PrEPTime frame: baseline, 1, 3, 6 months
  • RemovedCDC risk estimator scoresTime frame: baseline, 1, 3, 6 months
  • RemovedFrequency of game useTime frame: 1, 3, 6 months
  • RemovedPrEP screeningTime frame: baseline, 1, 3, 6 months
  • RemovedPrEP locator useTime frame: baseline, 1, 3, 6 months
  • RemovedDuration of game useTime frame: 1, 3, 6 months
  • RemovedReasons for continued or discontinued use of gameTime frame: 1, 3, 6 months
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Results posted
    Start date Jun 24, 2021→Nov 1, 2023
    Primary completion Oct 31, 2024→May 1, 2024
    Study completion Oct 31, 2024→May 1, 2024
    Enrollment 300→309
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedHIV testingTestingTime frame: prior 6 months → assessed at 6 months from enrollment
    Secondary outcomes 3 edited, 2 added, 9 removed
    What changed in the outcomes
    • EditedIntentNumber of Participants Intending to testTest for HIVTime frame: baseline, 1, 3, 6 months → assessed at 6 months after enrollment
    • EditedPrEP useUse/uptakeUptakeTime frame: baseline, 1, 3, 6 months → assessed at 6 months post enrollment
    • EditedHIV locator useTesting LocatorTime frame: baseline, 1, 3, 6 months → assessed at 3 months post enrollment
    • AddedMean HIV Knowledge Test Scores for the Two GroupsTime frame: assessed at 6 months post enrollment
    • AddedMean PrEP Knowledge Score for Each of the Two GroupsTime frame: assessed at 6 months post enrollment
    • RemovedHIV knowledgeTime frame: baseline, 1, 3, 6 months
    • RemovedHIV risk perception and behaviorsTime frame: baseline, 1, 3, 6 months
    • RemovedKnowledge of PrEPTime frame: baseline, 1, 3, 6 months
    • RemovedCDC risk estimator scoresTime frame: baseline, 1, 3, 6 months
    • RemovedFrequency of game useTime frame: 1, 3, 6 months
    • RemovedPrEP screeningTime frame: baseline, 1, 3, 6 months
    • RemovedPrEP locator useTime frame: baseline, 1, 3, 6 months
    • RemovedDuration of game useTime frame: 1, 3, 6 months
    • RemovedReasons for continued or discontinued use of gameTime frame: 1, 3, 6 months
    + 5 other changes: index terms, verification date, responsible party, arm descriptions and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04917575
Collaborators
Media Rez
Responsible party
Amanda D. Castel (Principal Investigator, George Washington University) — Principal investigator
First posted
Jun 8, 2021
Start date
Nov 1, 2023
Primary completion
May 1, 2024
Completion
May 1, 2024
Results posted
Nov 16, 2026
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion